Latest Cashflow News

Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.

Locality Planning Energy Holdings (LPE) reports a cashflow positive half-year and reduces debt, while securing a landmark energy management contract for Queensland's largest social housing project.

Alcidion Group Limited reported robust Q2 FY25 sales of $13.1 million and improved cash flow, reinforcing its forecast to achieve EBITDA and cashflow positivity by the end of FY25.

Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.

Rumble Resources has unveiled a significant resource upgrade at its Western Queen Project alongside a strategic joint venture to fast-track gold production, while advancing metallurgical progress at its Earaheedy zinc project.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

RemSense Technologies delivered a cashflow positive Q2 FY2025, driven by a 78% surge in customer receipts and successful execution of major global contracts. The company’s virtualplant platform continues to gain traction across mining, oil and gas, and new industrial sectors.

Perseus Mining reported a 9% rise in gold production and a robust cash and bullion balance of US$704 million in Q2 FY25, alongside strategic progress on its CMA underground and Nyanzaga projects.

Dreadnought Resources has released a robust scoping study for its Star of Mangaroon gold project, targeting initial production of around 20,000 ounces at a high grade of 10 g/t. The study outlines strong financial metrics and sets the stage for potential production in 2025, backed by a processing agreement with Black Cat Syndicate.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.

AIC Mines delivered a robust December quarter with record copper production at Eloise and promising exploration results at Jericho, underpinning its growth strategy.